Evidence map›Paper›PMID 38615883›Full record

ArticleMicrobes and infection

Systemic inflammatory Th1 cytokines during Trypanosoma cruzi infection disrupt the typical anatomical cell distribution and phenotypic/functional characteristics of various cell subsets within the thymus.

Maria Estefania Viano, Natalia Soledad Baez, Constanza Savid-Frontera, Ruth Eliana Baigorri, Brenda Dinatale, Maria Florencia Pacini, Camila Bulfoni Balbi, Florencia Belén Gonzalez, Laura Fozzatti, Nicolas Leonel Lidón and 6 more

Abstract read
In one paragraph

Article in Microbes and infection. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Bystander CD8Frontiers in immunology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Maria Estefania VianoInmunología, CIBICI-CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Argentina.
Natalia Soledad BaezInmunología, CIBICI-CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Argentina.
Constanza Savid-FronteraInmunología, CIBICI-CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Argentina.
Ruth Eliana BaigorriInmunología, CIBICI-CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Argentina.
Brenda DinataleInstituto de Inmunología Clínica y Experimental de Rosario (IDICER CONICET-UNR), Argentina.
Maria Florencia PaciniInstituto de Inmunología Clínica y Experimental de Rosario (IDICER CONICET-UNR), Argentina.
Camila Bulfoni BalbiInstituto de Inmunología Clínica y Experimental de Rosario (IDICER CONICET-UNR), Argentina.
Florencia Belén GonzalezInstituto de Inmunología Clínica y Experimental de Rosario (IDICER CONICET-UNR), Argentina.
Laura FozzattiInmunología, CIBICI-CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Argentina.
Nicolas Leonel LidónInmunología, CIBICI-CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Argentina.
Howard A YoungCancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick MD 21702-1201, USA.
Deborah L HodgeCancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick MD 21702-1201, USA.
Fabio CerbanInmunología, CIBICI-CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Argentina.
Cinthia Carolina StempinInmunología, CIBICI-CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Argentina.
Ana Rosa PérezInstituto de Inmunología Clínica y Experimental de Rosario (IDICER CONICET-UNR), Argentina; Centro de Investigación y Producción de Reactivos Biológicos (CIPREB), Facultad de Cs. Médicas de la Universidad Nacional de Rosario (UNR), Argentina.
Maria Cecilia Rodriguez-GalánInmunología, CIBICI-CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Argentina. Electronic address: maria.rodriguez.galan@unc.edu.ar.

Funding

Control of Cytokine Gene Expression in LymphoidMyeloid CellsZIABC009283 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI YOUNG, HOWARD · 2009 to 2024
$22.7M
CONTROL OF HUMAN INTERFERON GAMMA GENE EXPRESSIONZ01BC009283 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI YOUNG, HOWARD A · 1996 to 2008
$2.6M
Intramural NIH HHS Z01 BC009283Intramural NIH HHS ZIA BC009283
6 · The paper itself

Abstract

The thymus plays a crucial role in T cell differentiation, a complex process influenced by various factors such as antigens, the microenvironment and thymic architecture. The way the thymus resolves infections is critical, as chronic persistence of microbes or inflammatory mediators can obstruct the differentiation. Here, we illustrate that following inflammatory T helper 1 infectious processes like those caused by Candida albicans or Trypanosoma cruzi, single positive thymocytes adopt a mature phenotype. Further investigations focused on T. cruzi infection, reveal a substantial existence of CD44

Indexed as

Chagas DiseaseCytokinesMice, KnockoutTh1 CellsThymus GlandTrypanosoma cruziAnimalsCell DifferentiationInflammationInterferon-gammaMiceMice, Inbred C57BLCytokinesInterferon-gammaCandida albicansIFNγIL-12IL-18ThymusTrypanosoma cruzi

Identifiers

PMID38615883
PMCPMC11227410

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.